What is the 52 Week High and Low of Ajanta Pharma Share Price?

The 52 week high and low prices of Ajanta Pharma share price is 3506.9 & 2329.9. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Ajanta Pharma Share price

Q: How to buy Ajanta Pharma Share at Choice?

To buy Ajanta Pharma stocks , log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Ajanta Pharma, choose your preferred order type, and place the trade.

AJANTPHARM

Healthcare Large Cap

3348.6

41.00 (1.24%)

NSE

BSE

Last updated on 10 Jul, 2026 | 15:54 IST

BUYSELL

Today's High

3366.00

Today's Low

3290.90

52 Week Low

2329.90

52 Week High

3506.90

Ajanta Pharma share price chart

ChartIQ

TradingView

Ajanta Pharma Share Key Metrics

Volume

55151.00

Market Cap

41835.94 CR

LTQ@LTP

1@3348.60

ATP

3338.66

Var Margin

15.26 %

Circuit Range

2646.1-3969.1

Delivery %

47.55 %

Value

18.41 CR

ASM/GSM

No

Market Lot

1

Summary

AJANTPHARM stock price is ₹3348.6 as of 10 Jul, 2026. The stock intraday movement has stayed between ₹3290.90 and ₹3366.00, while Ajanta Pharma share price 52 week high low is ₹2329.90 & ₹3506.90.

In terms of trading activity, AJANTPHARM share price has recorded a volume of 55,151 shares. The Ajanta Pharma has a market cap of ₹124935624. The stock’s Average Traded Price (ATP) stands at ₹3338.66, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1 @ ₹3348.60.

The Ajanta Pharma upper circuit limit is ₹3969.10 & The Ajanta Pharma lower circuit limit is ₹2646.10, with a Value of ₹18.41 CR. The Delivery Percentage for the day is 47.55%.

Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.

Ajanta Pharma Fundamentals

P/E Ratio

39.1

P/B Ratio

9.13

Div. Yield

0.85

Sector P/E

69.5

Sector P/B

3.24

Sec. Div. Yield

0.52

Ajanta Pharma Resistance and Support

Pivot 3318.57

Resistance

First Resistance

3374.14

Second Resistance

3440.67

Third Resistance

3496.24

Support

First Support

3252.04

Second Support

3196.47

Third Support

3129.94

Ajanta Pharma Shareholding Pattern

2016-17
2018-19
2019-20
2020-21
2021-22
2022-23
2023-24
2024-25
2025-26
2026-27

Total Promoters

Segment

Percent

Total Promoters

66.25%

Mutual Fund

15.22%

Insurance

2.7%

Foreign Institutional Investors

8.26%

Domestic Institutional Investors

0.46%

Retail

7.12%

Others

-0.01%

Total Promoters

MAR '26

66.25%

Ajanta Pharma Corporate Actions

Date	Agenda
2026-05-05	Audited Results
2026-01-30	Quarterly Results
2025-11-03	Quarterly Results & Interim Dividend
2025-07-28	Quarterly Results & Others
2025-04-30	Audited Results & A.G.M.
2025-01-30	Quarterly Results

Ajanta Pharma News

Ajanta Pharma Ltd - 532331 - Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

Ajanta Pharma's promoter group entities, Aayush M. Agrawal, Aayush M. Agrawal (Trustee), and Gabs Investments Pvt Ltd, pledged a total of 66.33 lakh shares. This represents approximately 5.31% of the company's total paid-up share capital. The shares were pledged as security for the issuance of non-convertible debentures.

Jul 08 2026 14:13:25

Ajanta Pharma Ltd - 532331 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

Ajanta Pharma's promoter group has pledged 6.63 million shares, equivalent to 5.31% of the company's total equity, as security for debentures worth approximately Rs. 3873 crore. This move indicates increased leverage by promoter entities.

Jul 03 2026 11:12:14

Ajanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

Promoters Aayush Agrawal Trust and Aayush Agrawal pledged 1,006,726 shares of Ajanta Pharma, amounting to 0.80% of the total share capital. This pledge was made to secure a new loan from CTL Trusteeship Limited.

Jul 03 2026 10:31:10

Ajanta Pharma Ltd - 532331 - Update On US FDA Inspection At Paithan Manufacturing Facility

Ajanta Pharma received the USFDA Establishment Inspection Report (EIR) for its Paithan manufacturing facility. The inspection was classified as Voluntary Action Indicated (VAI), meaning no enforcement action will be taken.

Jul 02 2026 13:51:16

Ajanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

Ajanta Pharma's promoter, Ravi Agrawal (Trustee Ravi Agrawal Trust), released pledge on 1,732,792 equity shares, representing 1.39% of the company's total share capital. This action reduces the promoter's overall pledged holding to 1.36% of the total share capital.

Jun 27 2026 12:44:44

Ajanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

Ajanta Pharma's promoter, Ravi Agrawal (Trustee Ravi Agrawal Trust), released a pledge on 2,326,289 equity shares. This reduces the promoter's total pledged holding from 4.61% to 2.75% of the company's share capital, citing excess pledge as the reason.

Jun 19 2026 14:25:43

Name	Position
Gaurang Shah	Sr. VP – Legal, Company Secretary & Compliance Officer
Mannalal B Agrawal	Chairman

Ajanta Pharma Similar Stocks

Abbott India Ltd.

27165.00

395.00 (1.48%)

Ipca Laboratories Ltd.

1787.90

17.50 (0.99%)

Anthem Biosciences Ltd.

754.70

2.70 (0.36%)

Gland Pharma Ltd.

2479.40

9.90 (0.40%)

Glaxosmithkline Pharmaceuticals Ltd.

2438.20

-2.20 (0.09%)

Narayana Hrudayalaya Ltd.

2027.30

34.10 (1.71%)

Aster DM Quality Care Ltd.

808.90

1.75 (0.22%)

JB Chemicals & Pharmaceuticals Ltd.

2435.50

-9.00 (0.37%)

Ajanta Pharma FAQs

The Buying Price of Ajanta Pharma share is 3348.6 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Ajanta Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Ajanta Pharma, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Ajanta Pharma shares is 39.1. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Ajanta Pharma shares is 9.13. Useful to assess the stock's value relative to its book value.

To assess Ajanta Pharma’s valuation compare Sector P/E, P/B which are 69.5 & 3.24 with sector averages, along with growth rates and financial metrics.

The Market Cap of Ajanta Pharma is 41835.94 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Ajanta Pharma share price is 3506.90 & 2329.90. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Ajanta Pharma belongs to the Healthcare sector.